Long-Chain Noncoding RNA ADAMTS9-AS2 Regulates Proliferation, Migration, and Apoptosis in Bladder Cancer Cells Through Regulating miR-182-5p

被引:8
作者
Guo, Qing [1 ]
Ni, Pinghua [1 ]
Dai, Yi [1 ]
Hu, Jianming [1 ]
Yao, Yizhe [1 ]
机构
[1] Fifth Peoples Hosp Kunshan, Dept Urinary Surg, 350 Shaoqing East Rd, Suzhou 215300, Jiangsu, Peoples R China
关键词
bladder cancer; ADAMTS9-AS2; proliferation; apoptosis; miR-182-5p; LNCRNA ADAMTS9-AS2; TUMOR-SUPPRESSOR; MICRORNAS; EXPRESSION; STATISTICS; INVASION;
D O I
10.1089/jir.2020.0137
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The long-chain noncoding RNA ADAMTS9-AS2 functions as a tumor suppressor gene in many cancers. However, the underlying mechanism remains to be fully elucidated in bladder cancer (BC). ADAMTS9-AS2 exhibited a lower expression level in BC samples and cell lines. In addition, overexpression of ADAMTS9-AS2 obviously suppressed proliferation and migration, and induced apoptosis of T24 cells, while transfection with the ADAMTS9-AS2 inhibitor had opposite results in 5637 cells. Furthermore, miR-182-5p was the target microRNA of ADAMTS9-AS2 and was negatively correlated with ADAMTS9-AS2 expression. Upregulation of miR-182-5p reversed the effects of ADAMTS9-AS2 overexpression on biological function in T24 cells. ADAMTS9-AS2 was a tumor suppressor that inhibited BC cell proliferation and induced cellular apoptosis by targeting miR-182-5p, and it could be a promising target for BC treatment.
引用
收藏
页码:60 / 71
页数:12
相关论文
共 37 条
[1]   Role of lncRNAs in the cancer development and progression and their regulation by various phytochemicals [J].
Baskaran, Rathinasamy ;
Velmurugan, Bharath Kumar .
BIOMEDICINE & PHARMACOTHERAPY, 2018, 102 :242-248
[2]   RETRACTED: Down-regulation of lncRNA ADAMTS9-AS2 contributes to gastric cancer development via activation of PI3K/Akt pathway (Retracted article. See vol. 142, 2021) [J].
Cao, Bole ;
Liu, Cuixia ;
Yang, Guifeng .
BIOMEDICINE & PHARMACOTHERAPY, 2018, 107 :185-193
[3]   Noncoding RNA:RNA Regulatory Networks in Cancer [J].
Chan, Jia Jia ;
Tay, Yvonne .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (05)
[4]   Long non-coding RNAs in anti-cancer drug resistance [J].
Chen, Qin-nan ;
Wei, Chen-chen ;
Wang, Zhao-xia ;
Sun, Ming .
ONCOTARGET, 2017, 8 (01) :1925-1936
[5]   Cancer Statistics in China, 2015 [J].
Chen, Wanqing ;
Zheng, Rongshou ;
Baade, Peter D. ;
Zhang, Siwei ;
Zeng, Hongmei ;
Bray, Freddie ;
Jemal, Ahmedin ;
Yu, Xue Qin ;
He, Jie .
CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) :115-132
[6]   Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: persisting uncertainties [J].
Choueiri, Toni K. ;
Raghavan, Derek .
NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (08) :444-454
[7]   Long noncoding RNA (lincRNA), a new paradigm in gene expression control [J].
Deniz, Emre ;
Erman, Batu .
FUNCTIONAL & INTEGRATIVE GENOMICS, 2017, 17 (2-3) :135-143
[8]   Long non-coding RNAs as emerging regulators of differentiation, development, and disease [J].
Dey, Bijan K. ;
Mueller, Adam C. ;
Dutta, Anindya .
TRANSCRIPTION-AUSTIN, 2014, 5 (04)
[9]   MicroRNAs in Bladder Outlet Obstruction: Relationship to Growth and Matrix Remodelling [J].
Ekman, Mari ;
Albinsson, Sebastian ;
Uvelius, Bengt ;
Sward, Karl .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 119 :5-17
[10]   MicroRNAs as Regulators of Signal Transduction in Urological Tumors [J].
Fendler, Annika ;
Stephan, Carsten ;
Yousef, George M. ;
Jung, Klaus .
CLINICAL CHEMISTRY, 2011, 57 (07) :954-968